4.6 Article

General dual functionalisation of biomacromolecules via a cysteine bridging strategy

期刊

ORGANIC & BIOMOLECULAR CHEMISTRY
卷 18, 期 22, 页码 4224-4230

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0ob00907e

关键词

-

资金

  1. AstraZeneca
  2. Cambridge Trusts
  3. EPSRC [EP/P020291/1]
  4. Trinity College Cambridge
  5. GlaxoSmithKline/EPSRC
  6. Royal Society (Wolfson Research Merit Award)
  7. EPSRC [EP/P020291/1] Funding Source: UKRI

向作者/读者索取更多资源

Site-selective modification of peptides and proteins has resulted in the development of a host of novel tools for the study of cellular systems or the synthesis of enhanced biotherapeutics. There is a need for useful methodologies that enable site-selective modification of native peptides or proteins, which is even more prevalent when modification of the biomolecule with multiple payloads is desired. Herein, we report the development of a novel dual functional divinylpyrimidine (dfDVP) platform that enables robust and modular modification of peptides, antibody fragments and antibodies. These biomacromolecules could be easily functionalised with a range of functional payloads (e.g.fluorescent dyes, cytotoxic warheads or cell-penetrating tags). Importantly, the dual functionalised peptides and antibodies demonstrated exquisite bioactivity in a range ofin vitrocellular assays, showcasing the enhanced utility of these bioactive conjugates.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据